Insider Transactions in Q4 2020 at Black Diamond Therapeutics, Inc. (BDTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
2,800
-0.04%
|
$92,400
$33.03 P/Share
|
|
Oct 15
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
2,473
-0.04%
|
$81,609
$33.03 P/Share
|
|
Oct 15
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
327
-0.03%
|
$10,791
$33.03 P/Share
|
|
Oct 14
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
4,859
-0.08%
|
$160,347
$33.09 P/Share
|
|
Oct 14
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
642
-0.06%
|
$21,186
$33.09 P/Share
|
|
Oct 14
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
5,501
-0.07%
|
$181,533
$33.09 P/Share
|
|
Oct 13
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
10,370
-0.18%
|
$342,210
$33.39 P/Share
|
|
Oct 13
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
1,369
-0.14%
|
$45,177
$33.39 P/Share
|
|
Oct 13
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
11,739
-0.16%
|
$387,387
$33.39 P/Share
|
|
Oct 12
2020
|
Brent Hatzis Schoch |
SELL
Open market or private sale
|
Direct |
4,078
-31.2%
|
$134,574
$33.18 P/Share
|
|
Oct 12
2020
|
Brent Hatzis Schoch |
BUY
Exercise of conversion of derivative security
|
Direct |
4,078
+36.55%
|
$12,234
$3.2 P/Share
|
|
Oct 12
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
353
-0.01%
|
$11,649
$33.11 P/Share
|
|
Oct 12
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
47
-0.0%
|
$1,551
$33.11 P/Share
|
|
Oct 12
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
400
-0.01%
|
$13,200
$33.11 P/Share
|
|
Oct 09
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
3,357
-0.06%
|
$110,781
$33.67 P/Share
|
|
Oct 09
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
443
-0.04%
|
$14,619
$33.67 P/Share
|
|
Oct 09
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
3,800
-0.05%
|
$125,400
$33.67 P/Share
|
|
Oct 08
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
16,276
-0.14%
|
$537,108
$33.47 P/Share
|
|
Oct 08
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
2,149
-0.11%
|
$70,917
$33.47 P/Share
|
|
Oct 08
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
18,425
-0.12%
|
$608,025
$33.47 P/Share
|
|
Oct 08
2020
|
Thomas Leggett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-100.0%
|
$99,000
$33.53 P/Share
|
|
Oct 08
2020
|
Thomas Leggett Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$30,000
$10.86 P/Share
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
294,920
-54.15%
|
-
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
5,312
+48.21%
|
-
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
24,590
-0.43%
|
$811,470
$33.56 P/Share
|
|
Oct 07
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
3,246
-0.31%
|
$107,118
$33.56 P/Share
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
1,471
+6.36%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
294,920
-54.15%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
5,312
+48.21%
|
-
|
|
Oct 07
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
27,836
-0.37%
|
$918,588
$33.56 P/Share
|
|
Oct 06
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct |
15,980
-0.28%
|
$527,340
$33.26 P/Share
|
|
Oct 06
2020
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect |
2,110
-0.2%
|
$69,630
$33.26 P/Share
|
|
Oct 06
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
18,090
-0.24%
|
$596,970
$33.26 P/Share
|
|
Oct 05
2020
|
Christopher D. Roberts Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,500
-95.46%
|
$77,500
$31.59 P/Share
|
|
Oct 05
2020
|
Christopher D. Roberts Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$25,000
$10.86 P/Share
|
|
Oct 01
2020
|
David M. Epstein |
SELL
Open market or private sale
|
Direct |
12,000
-1.64%
|
$360,000
$30.33 P/Share
|
|
Oct 01
2020
|
David M. Epstein |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.41%
|
$18,000
$6.42 P/Share
|